VVOS · Vivos Therapeutics, Inc.
$0.30
-0.04 (-11.94%)
At close · Aug 17
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Without additional financing, these factors raise substantial doubt regarding the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$6.91M
Shares
20.12M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-14 | 2026-06-30 | |
| 8-K | 2026-08-11 | 2026-08-05 | |
| 8-K | 2026-08-03 | 2026-07-31 | |
| 8-K | 2026-07-07 | — | |
| 8-K | 2026-06-25 | — | |
| 8-K | 2026-06-16 | 2026-06-15 | |
| 8-K | 2026-06-16 | — | |
| 8-K | 2026-06-08 | — | |
| 10-Q | 2026-05-20 | 2026-03-31 | |
| 8-K | 2026-04-22 | — | |
| 8-K | 2026-04-15 | — | |
| 10-K | 2026-04-15 | 2025-12-31 | |
| 8-K | 2026-04-03 | — | |
| 8-K | 2026-02-06 | — | |
| 8-K | 2026-01-20 | — | |
| 8-K | 2026-01-16 | — | |
| 8-K | 2025-12-17 | 2025-12-16 | |
| 8-K | 2025-12-05 | — | |
| 10-Q | 2025-11-19 | 2025-09-30 | |
| 8-K | 2025-11-19 | — | |
| 8-K | 2025-11-04 | — | |
| 8-K | 2025-10-24 | — | |
| DEF 14A | 2025-09-29 | 2025-09-26 | |
| 8-K | 2025-09-18 | 2025-09-17 | |
| 8-K | 2025-09-12 | — | |
| 8-K/A | 2025-08-25 | 2025-06-09 | |
| 8-K | 2025-08-20 | — | |
| 10-Q | 2025-08-19 | 2025-06-30 | |
| 8-K | 2025-06-13 | — | |
| 8-K | 2025-06-06 | — | |
| 8-K | 2025-05-23 | — | |
| 10-Q | 2025-05-15 | 2025-03-31 | |
| 8-K | 2025-05-15 | — | |
| 8-K | 2025-04-17 | — | |
| 8-K | 2025-03-31 | — | |
| 10-K | 2025-03-31 | 2024-12-31 | |
| 8-K | 2025-02-14 | — | |
| 8-K | 2024-12-23 | — | |
| 8-K | 2024-11-27 | — | |
| 8-K | 2024-11-14 | — | |
| 10-Q | 2024-11-14 | 2024-09-30 | |
| DEF 14A | 2024-10-07 | — | |
| 8-K | 2024-09-20 | — | |
| 8-K | 2024-09-18 | — | |
| 8-K | 2024-09-17 | — | |
| 8-K | 2024-09-12 | — | |
| 8-K | 2024-08-15 | 2024-08-14 | |
| 10-Q | 2024-08-14 | 2024-06-30 | |
| 10-K/A | 2024-07-30 | 2023-12-31 | |
| 8-K | 2024-07-10 | — |
Showing 1–50 of 110 filings
Key facts
CIK
1716166
CUSIP
92859E207
13F (30d)
21 filings
21 filers
Visit website
Investor relations